Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Cassava Sciences Inc’s stock clocked out at $2.82, up 2.17% from its previous closing price of $2.76. In other words, the price has increased by $2.17 from its previous closing price. On the day, 1.57 million shares were traded.
Ratios:
To gain a deeper understanding of SAVA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.62 and its Current Ratio is at 11.62. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On October 08, 2024, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $116.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 29 ’24 when Kupiec James William sold 4,000 shares for $3.87 per share. The transaction valued at 15,480 led to the insider holds 0 shares of the business.
Schoen Eric sold 59,800 shares of SAVA for $230,828 on Nov 29 ’24. The Chief Financial Officer now owns 11,500 shares after completing the transaction at $3.86 per share. On Nov 29 ’24, another insider, Schoen Eric, who serves as the Chief Financial Officer of the company, sold 2,000 shares for $3.82 each. As a result, the insider received 7,640 and left with 0 shares of the company.
Stock Price History:
Over the past 52 weeks, SAVA has reached a high of $42.20, while it has fallen to a 52-week low of $2.23. The 50-Day Moving Average of the stock is 11.05%, while the 200-Day Moving Average is calculated to be -82.89%.
Shares Statistics:
A total of 48.20M shares are outstanding, with a floating share count of 41.98M. Insiders hold about 13.11% of the company’s shares, while institutions hold 36.25% stake in the company.
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$0.55 and -$0.55 for the fiscal current year, implying an average EPS of -$0.55.
